Table 1 Clinical profiles of patients included in this study
Patient background | Group A (n = 26) | Group B (n = 63) | Group C (n = 110) | Group D (n = 36) |
|---|---|---|---|---|
Age (median and interquartile range) | 45.5 (42–51) | 46 (43–51) | 45 (41–48)45 | (39–47) |
Stage (number) | ||||
0 | 8 | 0 | 0 | 1 |
I | 15 | 49 | 16 | 16 |
II | 3 | 14 | 68 | 13 |
III | 0 | 0 | 25 | 2 |
IV | 0 | 0 | 1 | 1 |
Unclear | 0 | 0 | 0 | 3 |
Chemotherapy (number) | ||||
0 | 0 | 110 | 18 | |
DOC-FEC | – | – | 58 | 4 |
DOC-EC | – | – | 0 | 3 |
TC | – | – | 43 | 0 |
EC | – | – | 0 | 8 |
AC-T | – | – | 7 | 1 |
AC | – | – | 1 | 0 |
T | – | – | 1 | 2 |